Country/territory: Singapore
Sector:
Government
The articles listed below published by authors from Agency for Science, Technology and Research (A*STAR), organized by journal and article, represent the research output in Count and Share according to the subject or journal group selected above.
| Journal | Count | Share |
|---|---|---|
|
ACS Nano |
4 | 0.27 |
|
Acta Biomaterialia |
1 | 0.01 |
|
Advanced Materials |
3 | 0.13 |
|
American Journal of Clinical Nutrition |
4 | 1.08 |
|
American Journal of Respiratory and Critical Care Medicine |
1 | 0.04 |
|
Angewandte Chemie International Edition |
1 | 0.02 |
|
Brain |
2 | 0.23 |
|
Cancer Cell |
2 | 0.04 |
|
Cancer Research |
3 | 0.53 |
|
Cell Metabolism |
1 | 0.61 |
|
Cell Stem Cell |
1 | 0.03 |
|
Chemical Science |
1 | 0.09 |
|
Diabetes Care |
1 | 0.03 |
|
Gut |
2 | 0.24 |
|
Immunity |
1 | 0.03 |
|
International Journal of Obesity |
3 | 1.10 |
|
Journal of Clinical Investigation |
3 | 0.44 |
|
Journal of Experimental Medicine |
1 | 0.02 |
|
Journal of Neuroscience |
2 | 0.31 |
|
Journal of Physiology |
1 | 0.28 |
|
Journal of the American Chemical Society |
3 | 0.19 |
|
Journal of the National Cancer Institute |
2 | 0.06 |
|
Macromolecules |
1 | 0.08 |
|
Molecular Psychiatry |
1 | 0.62 |
|
Nature |
5 | 0.22 |
|
Nature Biotechnology |
1 | 0.09 |
|
Nature Cell Biology |
2 | 1.45 |
|
Nature Communications |
27 | 5.85 |
|
Nature Genetics |
1 | 0.15 |
|
Nature Immunology |
4 | 0.63 |
|
Nature Materials |
1 | 0.01 |
|
Nature Medicine |
1 | 0.01 |
|
Nature Nanotechnology |
4 | 0.15 |
|
Proceedings of the National Academy of Sciences of the United States of America |
6 | 0.72 |
|
Science |
5 | 1.15 |
|
Science Advances |
7 | 1.25 |
|
Science Translational Medicine |
2 | 0.18 |
|
The BMJ |
1 | 0.02 |
|
The Journal of Allergy and Clinical Immunology |
1 | 0.01 |
|
The Lancet |
1 | 0.03 |
|
The Lancet Oncology |
1 | 0.02 |
|
The Lancet Psychiatry |
1 | 0.02 |
Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.